Reshape Lifesciences Inc Revenue Growth Rates (RSLS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Reshape Lifesciences Inc  (NASDAQ: RSLS)
 

RSLS's Revenue Growth by Quarter and Year

Reshape Lifesciences Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RSLS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.03
FY 0.03

RSLSs Annual Revenue
Reshape Lifesciences Inc's Revenue in the fiscal year 2024 $ 7.06 millions
Reshape Lifesciences Inc's Revenue in the fiscal year 2023 $ 8.55 millions
Reshape Lifesciences Inc's Revenue in the fiscal year 2022 $ 11.24 millions
Reshape Lifesciences Inc's Revenue in the fiscal year 2021 $ 13.60 millions
Reshape Lifesciences Inc's Revenue in the fiscal year 2020 $ 11.30 millions




RSLS Revenue first quarter 2026 Y/Y Growth Comment
Reshape Lifesciences Inc reported drop in Revenue in the first quarter 2026 by -96.33% to $ 0.03 millions, from the same quarter in 2025.
The fall in the first quarter 2026 Reshape Lifesciences Inc's Revenue compares unfavorably to the Company's average Revenue doubling of 137.58%.

Looking into first quarter 2026 results within Major Pharmaceutical Preparations industry 200 other companies have achieved higher Revenue growth. While Reshape Lifesciences Inc' s Revenue meltdown of -96.33% ranks overall at the positon no. 3929 in the first quarter 2026.


RSLS Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -98.69 % 6.02 % -22.86 %
3rd Quarter September - -37.06 % -10.05 % -24.22 %
2nd Quarter June - -42.78 % -15.28 % -6.15 %
1st Quarter March -96.33 % -54.97 % -38.59 % -0.96 %
FY   - -60.05 % -16.82 % -

Financial Statements
Reshape Lifesciences Inc's first quarter 2026 Revenue $ 0.03 millions RSLS's Income Statement
Reshape Lifesciences Inc's first quarter 2025 Revenue $ 0.86 millions Quarterly RSLS's Income Statement


RSLS Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -97.58 % 16.24 % -1.37 %
3rd Quarter September - 11.71 % 1.55 % -4.37 %
2nd Quarter June - 29.07 % 1.57 % -26.37 %
1st Quarter March 5.3 % -62.45 % -11.57 % 11.07 %
FY (Year on Year)   - -60.05 % -16.82 % -


Back to RSLS Growth rate Comparisons >> Back to RSLS Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #201
Healthcare Sector #572
Overall #3929

Revenue Y/Y Growth Statistics
High Average Low
2272.62 % 137.58 % -100 %
 
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #201
Healthcare Sector #572
Overall #3929
Revenue Y/Y Growth Statistics
High Average Low
2272.62 % 137.58 % -100 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Reshape Lifesciences Inc's Q/Q Revenue Growth